Glenn HearsonJan 20, 2016RAINIER IPF StudyUpdated: Feb 21, 2023Completed IPF StudyMulti-Center Study Commercial Clinical Trial to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis. Principle Investigator: Professor Gisli Jenkins #ipfstudy
Completed IPF StudyMulti-Center Study Commercial Clinical Trial to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis. Principle Investigator: Professor Gisli Jenkins #ipfstudy
Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)
DYNamic assessment of multi-organ level dysfunction in patients recovering from COVID-19: DYNAMO COVID-19 findings published
Excel in Science Undergraduate students win abstract presentations at national meetings for their presentations titled “Will you regret dumping your X? Sex as a biological variable in Asthma Genomics”